Devika Chithrani discusses nanomaterial-based cancer theranostic approaches and their advantages for diagnosing and treating cancer.
Read the Article
Image courtesy of interviewee
Faculti comprises more than 8000+ researchers, policy makers and analysts.
Devika Chithrani discusses nanomaterial-based cancer theranostic approaches and their advantages for diagnosing and treating cancer.
Read the Article
Image courtesy of interviewee